| 词条 | Suvizumab |
| 释义 |
| Verifiedfields = changed | verifiedrevid = 470475254 | type = mab | image = | alt = | mab_type = mab | source = zu | target = HIV-1 | tradename = | Drugs.com = | MedlinePlus = | pregnancy_AU = | pregnancy_US = | pregnancy_category= | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = | routes_of_administration = | bioavailability = | protein_bound = | metabolism = | elimination_half-life = | excretion = | ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} | ChemSpiderID = none | CAS_number_Ref = {{cascite|changed|??}} | CAS_number = 914257-21-9 | ATC_prefix = none | ATC_suffix = | PubChem = | DrugBank_Ref = {{drugbankcite|correct|drugbank}} | DrugBank = | chemical_formula = | molecular_weight = }}Suvizumab is an antiviral and immunomodulator. It binds to HIV-1.[1] References1. ^{{cite journal |title = Proposed List number 102 of International Nonproprietary Names|journal = WHO Drug Information|year = 2009|url = http://www.who.int/entity/medicines/publications/druginformation/innlists/PL_102.pdf|format = PDF|publisher = World Health Organization|location = Geneva|issn = 1010-9609|page = 344|volume = 23|issue = 4}} {{monoclonals for infectious disease and toxins}}{{antiinfective-drug-stub}}{{monoclonal-antibody-stub}} 2 : Monoclonal antibodies|Experimental drugs |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。